Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 54 (2020): Issue 2 (June 2020)
Open Access
Significance of nuclear factor - kappa beta activation on prostate needle biopsy samples in the evaluation of Gleason score 6 prostatic carcinoma indolence
Marko Zupancic
Marko Zupancic
,
Boris Pospihalj
Boris Pospihalj
,
Snezana Cerovic
Snezana Cerovic
,
Barbara Gazic
Barbara Gazic
,
Primoz Drev
Primoz Drev
,
Marko Hocevar
Marko Hocevar
and
Andraz Perhavec
Andraz Perhavec
| Apr 21, 2020
Radiology and Oncology
Volume 54 (2020): Issue 2 (June 2020)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Research Article
Published Online:
Apr 21, 2020
Page range:
194 - 200
Received:
Jan 03, 2020
Accepted:
Mar 24, 2020
DOI:
https://doi.org/10.2478/raon-2020-0019
© 2020 Marko Zupancic, Boris Pospihalj, Snezana Cerovic, Barbara Gazic, Primoz Drev, Marko Hocevar, Andraz Perhavec, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Marko Zupancic
Department of Urology, General Hospital Slovenj Gradec
Slovenj Gradec, Slovenia
Boris Pospihalj
Department of Pathology, General Hospital Slovenj Gradec
Slovenj Gradec, Slovenia
Snezana Cerovic
Institute of Pathology and Forensic Medicine, Military Medical Academy Belgrade
Belgrade, Serbia
Barbara Gazic
Department of Pathology, Institute of Oncology Ljubljana
Ljubljana, Slovenia
Primoz Drev
Department of Pathology, Institute of Oncology Ljubljana
Ljubljana, Slovenia
Marko Hocevar
Department of Surgical Oncology, Institute of Oncology Ljubljana
Ljubljana, Slovenia
Andraz Perhavec
Department of Surgical Oncology, Institute of Oncology Ljubljana
Ljubljana, Slovenia